Balchem BCPC Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Net Sales by Business | ||||||
| Animal Nutrition and Health | $235.76M+2.1% | $230.85M+1.2% | $228.01M+1.5% | $224.54M+3.0% | $218.07M+1.6% | |
| Human Nutrition and Health | $672.56M+2.0% | $659.39M+2.9% | $640.62M+3.5% | $618.82M+2.1% | $605.97M+1.0% | |
| Specialty Products | $142.43M+1.0% | $140.98M+1.4% | $138.99M+1.8% | $136.5M+1.6% | $134.41M+1.3% | |
| Operating Income (Loss) by Business | ||||||
| Animal Nutrition and Health | $19.14M+2.4% | $18.69M+2.7% | $18.19M+1.0% | $18.01M+4.8% | $17.19M+22.7% | |
| Human Nutrition and Health | $155.95M+1.3% | $153.91M+2.0% | $150.9M+3.6% | $145.65M+3.5% | $140.67M+3.5% | |
| Specialty Products | $45.25M+5.5% | $42.9M+1.3% | $42.35M+2.5% | $41.33M+0.1% | $41.29M+3.5% | |
| Gross Profit by Business | ||||||
| Animal Nutrition and Health | $53.19M+5.2% | $50.56M+3.5% | $48.83M+2.3% | $47.73M+3.8% | $45.98M+6.2% | |
| Human Nutrition and Health | $251.07M+2.8% | $244.29M+1.9% | $239.82M+3.3% | $232.15M+2.9% | $225.56M+1.7% | |
| Specialty Products | $80.54M+4.1% | $77.37M+1.6% | $76.18M+1.5% | $75.09M+2.0% | $73.6M+0.4% | |
| Operating expenses by Business | ||||||
| Animal Nutrition and Health | $34.05M+6.8% | $31.87M+4.0% | $30.63M+3.1% | $29.72M+3.3% | $28.79M-1.7% | |
| Human Nutrition and Health | $95.12M+5.2% | $90.38M+1.6% | $88.92M+2.8% | $86.5M+1.9% | $84.89M-1.2% | |
| Specialty Products | $35.29M+2.4% | $34.46M+1.9% | $33.83M+0.2% | $33.75M+4.5% | $32.31M-3.3% | |
| Total Assets by Business | ||||||
| Animal Nutrition and Health | $702.68M+1.7% | $691.11M+2.3% | $675.74M+2.6% | $658.8M+2.7% | $641.53M+1.7% | |
| Human Nutrition and Health | $4.97B+0.8% | $4.94B+1.2% | $4.88B+1.0% | $4.83B+1.6% | $4.76B+0.6% | |
| Specialty Products | $688.55M+0.4% | $685.52M+1.6% | $674.73M+0.8% | $669.12M+1.2% | $661.22M-0.1% | |
| Cost of Sales by Business | ||||||
| Animal Nutrition and Health | $182.58M+1.3% | $180.29M+0.6% | $179.18M+1.3% | $176.8M+2.7% | $172.09M+0.4% | |
| Human Nutrition and Health | $421.49M+1.5% | $415.1M+3.6% | $400.8M+3.7% | $386.66M+1.6% | $380.41M+0.5% | |
| Specialty Products | $61.89M-2.7% | $63.61M+1.3% | $62.81M+2.3% | $61.42M+1.0% | $60.81M+2.3% | |
| D&A by Business | ||||||
| Animal Nutrition and Health | $7.38M+1.3% | $7.28M-1.5% | $7.39M-3.1% | $7.63M-3.4% | $7.89M-4.1% | |
| Human Nutrition and Health | $31.46M+4.5% | $30.12M+2.4% | $29.4M+2.8% | $28.59M-2.9% | $29.43M-7.1% | |
| Specialty Products | $7.39M+0.4% | $7.37M+3.4% | $7.12M+1.5% | $7.02M+0.4% | $6.99M-0.8% | |
| CapEx by Business | ||||||
| Animal Nutrition and Health | $16.88M+0.3% | $16.83M+14.6% | $14.68M+10.4% | $13.29M-1.7% | $13.52M+2.4% | |
| Human Nutrition and Health | $22.05M+3.9% | $21.22M+7.2% | $19.8M+24.5% | $15.9M+1.7% | $15.64M-11.0% | |
| Specialty Products | $4.5M-2.7% | $4.63M-5.0% | $4.87M+8.5% | $4.49M+3.5% | $4.34M+7.1% | |
| Net Sales by Product | ||||||
| Product Sales Revenue | $1.06B+1.9% | $1.04B+2.3% | $1.01B+2.8% | $984.2M+2.2% | $962.88M+1.1% | |
| Royalty Revenue | $1.92M+1.9% | $1.89M+5.2% | $1.8M+3.6% | $1.73M+4.3% | $1.66M-4.3% | |
| Cost of Sales by Product | ||||||
| Raw materials sold | $39.51M+0.1% | $39.48M+2.0% | $38.69M+4.8% | $36.91M+10.5% | $33.39M+12.1% | |
| Services provided | $4.63M-0.2% | $4.64M+2.0% | $4.55M0.0% | $4.55M+2.1% | $4.46M+0.8% | |
| Net Sales by Geography | ||||||
| Non-US | $286.24M+3.1% | $277.71M+6.2% | $261.52M+4.6% | $249.98M+5.2% | $237.61M+3.1% | |
| United States | $771.11M+1.5% | $759.45M+1.0% | $752.02M+2.2% | $735.95M+1.2% | $726.94M+0.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Balchem break its business down?
- Balchem (BCPC) reports net sales by business across 3 parts — Animal Nutrition and Health, Human Nutrition and Health and Specialty Products. Each is extracted from the segment footnotes and tracked over time.
- Where does Balchem's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Balchem's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.